Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HR18042 (Imrecoxib + Tramadol) for Postoperative Analgesia After Impacted Teeth Removal
NCT05470075Phase 2Terminated
- Sponsor
- Hengrui
- Start
- Aug 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imrecoxib + tramadol in postoperative pain, sponsored by Hengrui. Started Aug 2022; status: terminated.
02
Drugs
imrecoxib + tramadol
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05470075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05470075.